that we're just apparently not going to get based on the unfortunate need for cash and the corresponding dilution, I suggest doing some due diligence on ONCY (ONC in Canada). Lots of promise (but, IMO, less of a sure thing in terms of ultimate FDA approval than MNKD is at this point), and a lot fewer shares and market cap. They have been helped some by having various quasi-governmental bodies pick up the cost of some of their trials.